Discussions about heart health often center around blood pressure and cholesterol, with factors like poor sleep, smoking, family history of heart disease, and chronic stress thrown in. However, ...

The evidence for elevated triglycerides, as a cardiac risk factor, is nowhere near as well understood as the risk from high LDL and low HDL cholesterol. However, the growing body of epidemiologic ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...

ATLANTA, GA—Investigational agents that work by inhibiting apolipoprotein C-III (APOC3) are effective at reducing triglyceride levels, two phase IIb studies show. In Bridge-TIMI 73a, treatment with ...

Fenofibrate may be an effective treatment option in children with hypertriglyceridemia, in whom lower levels of triglycerides ...

ATLANTA -- A novel antisense mRNA drug slashed triglycerides in higher risk or moderate hypertriglyceridemia patients and in those with extremely elevated levels from familial chylomicronemia syndrome ...

Resistant starch is a non-digestible fiber that ferments in the large intestine, and consumption of it has previously been shown to have a positive effect on metabolism in animal studies. Now, a ...

Lowering cholesterol is one of the most effective ways to reduce your risk of heart disease, and it may soon be possible to get a one-and-done gene therapy to keep cholesterol and triglyceride levels ...

The Global "Hypertriglyceridemia Treatment Market" Informational Report provides an in-depth examination of market dynamics to help businesses make strategic decisions. It facilitates trend ...

—A recent study highlights the importance of differentiating familial chylomicronemia syndrome (FCS) from multifactorial chylomicronemia syndrome (MCS) for setting expectations, guiding genetic ...